OA08271A - Naphtyridinones-1,8 substituées, procédé pour leur obtention et compositions pharmaceutiques les contenant. - Google Patents

Naphtyridinones-1,8 substituées, procédé pour leur obtention et compositions pharmaceutiques les contenant.

Info

Publication number
OA08271A
OA08271A OA58819A OA58819A OA08271A OA 08271 A OA08271 A OA 08271A OA 58819 A OA58819 A OA 58819A OA 58819 A OA58819 A OA 58819A OA 08271 A OA08271 A OA 08271A
Authority
OA
OAPI
Prior art keywords
naphthyridinones
substituted
production
pharmaceutical compositions
compositions containing
Prior art date
Application number
OA58819A
Other languages
English (en)
French (fr)
Inventor
Margaret Hagar Sherlock
Sidney Randall Smith
Marvin Ira Siegel
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/716,003 external-priority patent/US4596809A/en
Priority claimed from US06/836,357 external-priority patent/US4687774A/en
Application filed by Schering Corp filed Critical Schering Corp
Publication of OA08271A publication Critical patent/OA08271A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
OA58819A 1985-03-25 1986-03-24 Naphtyridinones-1,8 substituées, procédé pour leur obtention et compositions pharmaceutiques les contenant. OA08271A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/716,003 US4596809A (en) 1985-03-25 1985-03-25 Substituted 1,8-naphthyridinones, useful as anti-allergic agents
US06/836,357 US4687774A (en) 1986-03-10 1986-03-10 Method for suppressing the immune response

Publications (1)

Publication Number Publication Date
OA08271A true OA08271A (fr) 1987-10-30

Family

ID=27109452

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58819A OA08271A (fr) 1985-03-25 1986-03-24 Naphtyridinones-1,8 substituées, procédé pour leur obtention et compositions pharmaceutiques les contenant.

Country Status (13)

Country Link
EP (1) EP0196024B1 (pt)
KR (1) KR900004829B1 (pt)
AU (1) AU579718B2 (pt)
DE (1) DE3675671D1 (pt)
DK (1) DK127086A (pt)
FI (1) FI84828C (pt)
GR (1) GR860757B (pt)
HU (1) HU196074B (pt)
IL (1) IL78230A0 (pt)
NO (1) NO164657C (pt)
NZ (1) NZ215562A (pt)
OA (1) OA08271A (pt)
PT (1) PT82257B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3786036T2 (de) * 1986-04-11 1993-09-09 Schering Corp Arylsubstituierte naphthyridin- und pyridopyrazin-derivate.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0092786B1 (en) * 1982-04-26 1987-01-07 Schering Corporation 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents
IL74147A (en) * 1984-02-02 1988-08-31 Merck & Co Inc 2-acylamino-hexahydro-arylquinolizines and salts thereof and pharmaceutical compositions containing them
DE3786036T2 (de) * 1986-04-11 1993-09-09 Schering Corp Arylsubstituierte naphthyridin- und pyridopyrazin-derivate.

Also Published As

Publication number Publication date
NO861178L (no) 1986-09-26
FI861194A0 (fi) 1986-03-21
AU579718B2 (en) 1988-12-08
KR860007263A (ko) 1986-10-10
KR900004829B1 (ko) 1990-07-07
EP0196024A1 (en) 1986-10-01
DK127086A (da) 1986-09-26
NO164657C (no) 1990-10-31
FI84828B (fi) 1991-10-15
DE3675671D1 (de) 1991-01-03
AU5502786A (en) 1986-10-02
PT82257A (en) 1986-04-01
GR860757B (en) 1986-07-28
EP0196024B1 (en) 1990-11-22
FI861194A (fi) 1986-09-26
FI84828C (fi) 1992-01-27
NO164657B (no) 1990-07-23
DK127086D0 (da) 1986-03-19
PT82257B (pt) 1988-07-29
IL78230A0 (en) 1986-07-31
NZ215562A (en) 1988-11-29
HU196074B (en) 1988-09-28
HUT41797A (en) 1987-05-28

Similar Documents

Publication Publication Date Title
FR2567131B1 (fr) Nouveaux derives de ganglioside, procede pour leur obtention et composition pharmaceutique les contenant
BE890574A (fr) Derive d'aminoalcoyl-furanne, procede pour sa preparation et composition pharmaceutique le contenant
FR2595351B1 (fr) Derives d'indole, procede pour leur preparation et compositions pharmaceutiques les contenant
OA07103A (fr) Nouvelles 1,2-diaminocyclobutène-3,4-diones, leur procédé de préparation et composition pharmaceutique les contenant.
BE885812A (fr) Derives d'acides 6beta-hydroxyalkylpenicillaniques, leur procede de production et compositions pharmaceutiques les contenant
FR2495154B1 (fr) 5'-aminoalkyl-4', 4, 8-trialkylpsoralenes, leur procede de production et composition pharmaceutique les contenant
OA07354A (fr) Nouveaux dérivés de céphalosporine, leur procédé de production et composition pharmaceutique les contenant.
BE861964A (fr) Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant
OA07172A (fr) Nouvelles thiazolidinediones, leur procédé de production et préparation pharmaceutique les contenant.
FR2569702B1 (fr) Nouvelle 4'-deschlororebeccamycine, composition pharmaceutique la contenant et procede pour sa preparation
FR2574793B1 (fr) Composes derives d'indole, compositions pharmaceutiques les contenant et procede pour leur preparation
FR2567519B1 (fr) Nouvelles isoindolinyl-alcoyl-piperazines, compositions pharmaceutiques les contenant, et leur procede de preparation
BE894927A (fr) Derives de l'ergoline, procede pour leur preparation et medicaments les contenant
OA07341A (fr) Nouveaux oximéthers, procédé pour leur préparation, agents contenant les nouveaux oximéthers et leur application.
FR2563519B1 (fr) Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2600061B1 (fr) Derives d'indole, composition pharmaceutique les contenant et procede pour leur preparation
FR2586686B1 (fr) Nouvelles substances antibiotiques et antitumorales, procede pour leur obtention et isolation; compositions pharmaceutiques les contenant
FR2574429B1 (fr) Acylglycannes extraits de klebsiella, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2704857B1 (fr) Nouvelles benzodioxines substituées, leur procédé de préparation et les compositions pharmaceutiques les contenant.
FR2615188B1 (fr) Derives d'hydrazine, procede d'obtention et compositions pharmaceutiques les contenant
FR2586681B1 (fr) Derives du methylene-dioxy-phenanthrene et du stilbene, procede pour leur preparation et medicaments les contenant
FR2513994B1 (fr) Tripeptides anorexigenes, procede pour leur preparation et compositions pharmaceutiques les contenant
OA08271A (fr) Naphtyridinones-1,8 substituées, procédé pour leur obtention et compositions pharmaceutiques les contenant.
FR2601951B1 (fr) Nouvelles tetrahydrocarbazolones, composition pharmaceutique les contenant et leur procede de preparation
FR2551440B1 (fr) Aminocyclopentanes, leur procede de preparation et compositions pharmaceutiques les contenant